Grupo de investigación cardiometabólica en atención primaria

Área de Cardiovascular

Consolidación de diversas líneas de investigación cardiometabólica

Consolidación de una red de colaboradores en el área de atención primaria

Coordinador
Dr. Jorge Navarro Pérez
jorge.navarro@uv.es  

INVESTIGADORES
R4 Senior

Jorge Navarro Pérez    

R3 Consolidado

Álvaro Bonet Pla
Carolina Mir Sánchez
José Sanfelix Genovés
Pilar Roca Navarro
Ruth Usó Talamantes

R2 Novel / Emergente

Carlos Momparler Martínez
Mª José Puchades Company
Nidia Ruiz Varea
Tomás Sánchez Ruiz
Victoria Gosalbes Soler

R1 Predoctoral

Carmina Martínez Vernia
Enrique Guinot Martínez
Irene Marco Moreno
Isabel Gabaldón Sánchez
José Luis Trillo Mata
Pablo Sabater Arnaldos
Ruth Uribes Fillol

STAFF
Colaborador/a

Marisa Gómez Arnedo
Vibiana Blanco Alvarado

Enfermero/a
Técnico/a

Mª Inmaculada Ruiz Saurí

Apoyo
Publicaciones
Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study. Molina P, Molina M, Pallardo L, Torralba J, Escudero V, Alvarez L, Peris A, Sanchez-Perez P, Gonzalez-Rico M, Puchades M, Fernandez-Najera J, Gimenez-Civera E, D’Marco L, Carrero J, Gorriz J. Journal Of Nephrology. 2021 Jan 4. doi: 10.1007/s40620-020-00916-9. PMID: 33394344

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort. Ruiz-Quintero M, Redón Mas J, Tellez-Plaza M, Cebrian-Cuenca A, Navarro Perez J, Menendez E, Perez-Navarro A, Fernandez-Gimenez A, Lopez-Pineda A, Quesada J, Pallares-Carratala V, Gil-Guillen V, Martín Moreno J, Bleda-Cano J, Carrascosa S, Carratala-Munuera C. Primary Care Diabetes. 2021 Feb;15(1):88-94. doi: 10.1016/j.pcd.2020.06.004. PMID: 32646765

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents. Ampudia-Blasco F, Palanca A, Trillo J, Navarro J, Real J. Journal of diabetes and its complications. 2021 Mar;35(3):107828. doi: 10.1016/j.jdiacomp.2020.107828. PMID: 33436143

A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project. Orozco-Beltran D, Quesada J, Bertomeu-Gonzalez V, Lobos-Bejarano J, Navarro Perez J, Gil-Guillen V, Garcia Ortiz L, Lopez-Pineda A, Castellanos-Rodriguez A, Lopez-Domenech A, Cardona-Llorens A, Carratala-Munuera C. Scientific Reports. 2020 Mar 16;10(1):4796. doi: 10.1038/s41598-020-61437-w. PMID: 32179807

A randomized controlled trial on carbohydrate antigen 125-guided diuretic treatment versus usual care in patients with acute heart failure and renal dysfunction. Nuñez Villota J, Llacer P, Garcia Blas S, Bonanad Lozano C, Ventura S, Nunez J, Sanchez R, Facila De La Esperanza R, De La Espriella Juan R, Vaquer Santamaria J, Cordero A, Roque M, Chamorro C, Bodí Peris V, Valero Picher E, Santas Olmeda E, Del Carmen Moreno M, Miñana Escriva G, Carratalá Calvo A, Rodriguez Borja E, Mollar Fernandez A, Palau P, Bosch M, Bertomeu-Gonzalez V, Lupon J, Navarro Perez J, Chorro Gascó F, Górriz Teruel J, Sanchis Fores J, Voors A, Bayes-Genis A, IMPROVE-HF Investigators. American Journal of Medicine. 2020 Mar;133(3):370-380.e4. doi: 10.1016/j.amjmed.2019.07.041. PMID: 31422111

Acute kidney injury in heart failure: a population study. Holgado Sánchez J, Lopez Forte C, Fernández Giménez A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Nuñez Villota J, Redón Mas J, Ruiz Hernandez A. Esc Heart Failure. 2020 Apr;7(2):415-422. doi: 10.1002/ehf2.12595. PMID: 32059081

Cardiovascular preventive recommendations. PAPPS 2020 update. Orozco-Beltran D, Brotons Cuixart C, Aleman Sanchez J, Banegas Banegas J, Cebrian-Cuenca A, Gil Guillen V, Martin Rioboo E, Navarro Perez J. Atencion Primaria. 2020 Nov;52 Suppl 2:5-31. doi: 10.1016/j.aprim.2020.08.002. PMID: 33388118

Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia. Blasco Cortes M, Buesa Gomez J, Colomina Rodríguez F, Forner Giner M, Galindo Puerto M, Navarro Perez J, Noceda Bermejo J, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal Of Medical Virology. 2020 Oct;92(10):1799-1801. doi: 10.1002/jmv.25922. PMID: 32320082

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain. Poveda J, Trillo Mata J, Rubio-Terres C, Rubio-Rodriguez D, Polanco A, Torres C. Expert Review of Pharmacoeconomics & Outcomes Research. 2020 Jun;20(3):295-303. doi: 10.1080/14737167.2019.1635014. PMID: 31220959

Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease. D’marco Gascón L, Puchades Company M, Górriz Teruel J, Romero Parra M, Lima-Martinez M, Soto C, Bermudez V, Raggi P. International Journal Of Molecular Sciences. 2020 Feb 1;21(3):978. doi: 10.3390/ijms21030978. PMID: 32024124

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists. Górriz Teruel J, Soler M, Navarro-Gonzalez J, Garcia-Carro C, Puchades M, D’marco Gascón L, Martinez Castelao A, Fernandez-Fernandez B, Ortiz A, Gorriz-Zambrano C, Navarro Perez J, Gorgojo-Martinez J. Journal of Clinical Medicine. 2020 Mar 30;9(4):947. doi: 10.3390/jcm9040947. PMID: 32235471

Hospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015. Domingo O, Alberto G, Ana Maria C, Jorge N, Vicente G, Quesada-Rico Jose A, Pomares-Gomez Francisco J, Adriana L, Concepcion C. Diabetes Research and Clinical Practice. 2020 Nov 23;171:108565. doi: 10.1016/j.diabres.2020.108565. PMID: 33242511

Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population Study. López Zumel M, Holgado Sánchez J, Ferrandez Izquierdo A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Bea Serrano C, Nuñez Villota J, Ferrer Albero A, Gamez Payá J, Ruiz Hernandez A, Redón Mas J. Journal of Clinical Medicine. 2020 Jun 15;9(6):1869. doi: 10.3390/jcm9061869. PMID: 32549339

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. Nuñez Villota J, Miñana Escriva G, Cardells Beltran I, Palau P, Llacer P, Facila L, Almenar L, Lopez Lereu M, Monmeneu Menadas J, Amiguet Comins M, González D’gregorio J, Serrano Alcalá A, Montagud V, Lopez-Vilella R, Valero Picher E, Garcia Blas S, Bodí Peris V, De La Espriella Juan R, Lupon J, Navarro Perez J, Górriz Teruel J, Sanchis Fores J, Chorro Gascó F, Comin-Colet J, Bayes Genis A, Myocardial-IRON Investigators. Journal of the American Heart Association. 2020 Feb 18;9(4):e014254. doi: 10.1161/JAHA.119.014254. PMID: 32067585

Prevalence of vertebral fractures and their prognostic significance in the survival in patients with chronic kidney disease stages 3‒5 not on dialysis. Castro-Alonso C, D’marco Gascón L, Pomes J, Del Amo Conill M, Isabel Garcia-Diez A, Molina P, Puchades Company M, Manuel Valdivielso J, Escudero V, Bover J, Navarro Gonzalez J, Ribas B, Manuel Pallardo L, Górriz Teruel J. Journal of Clinical Medicine. 2020 May 25;9(5):1604. doi: 10.3390/jcm9051604. PMID: 32466297

Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19. de Dios E, Rios-Navarro C, Perez-Sole N, Gavara J, Marcos-Garces V, Rodríguez E, Carratalá A, Forner MJ, Navarro J, Blasco ML, Bondia E, Signes-Costa J, Vila JM, Forteza MJ, Chorro 1MJ, Bodi V. Journal of Clinical Medicine. 2020 Oct 28;9(11):E3484. doi: 10.3390/jcm9113484. PMID: 33126723

The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study. Orozco-Beltran D, Navarro Perez J, Cebrian-Cuenca A, Alvarez-Guisasola F, Caride-Miana E, Mora G, Quesada J, Lopez-Pineda A, Cardona-Llorens A, Redón Mas J, Gil-Guillen V, Ferrandez Izquierdo A, Carratala-Munuera C. Primary Care Diabetes. 2020 Dec;14(6):678-684. doi: 10.1016/j.pcd.2020.06.003. PMID: 32605878

Efficacy of a cognitive and behavioral treatment for childhood obesity supported by the ETIOBE web platform. Baños RM, Oliver E, Navarro J, Vara MD, Cebolla A, Lurbe E, Pitti JA, Torró MI, Botella C. Psychology Health & Medicine. 2019 Jul;24(6):703-713. doi: 10.1080/13548506.2019.1566622. PMID: 30648879

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 toUnderuse. Data From the ESOSVAL Cohort From 2009 to 2015. Hurtado-Navarro I, García-Sempere A, Rodríguez-Bernal C, Sanfélix-Genovés J,Peiró S, Sanfélix-Gimeno G. Frontiers in pharmacology. 2019 Jul 10;10:768.  doi: 10.3389/fphar.2019.00768. PMID: 31354484

Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs. García-Sempere A, Hurtado I, Sanfélix-Genovés J, Rodríguez-Bernal C, Peiró S,Sanfélix-Gimeno G. Current medical research and opinión. 2019 Sep;35(9):1535-1544. doi: 10.1080/03007995.2019.1601944. PMID: 30924690

Management of hyperglycaemia with non-insulin drugs in adult patients with type 2 diabetes. Álvarez-Guisasola F, Orozco-Beltrán D, Cebrián-Cuenca AM, Ruiz Quintero MA, Angullo Martínez E, Ávila Lachica L, Ortega Millán C, Caride Miana E, Navarro-Pérez J, Sagredo Perez J, Barrot de la Puente J, Cos Claramunt FX. Atencion Primaria. 2019 Aug – Sep;51(7):442-451. doi: 10.1016/j.aprim.2019.05.014. PMID: 31320123

Measurement of health-related quality by multimorbidity groups in primary health care. Millá-Perseguer M, Guadalajara-Olmeda N, Vivas-Consuelo D, Usó-Talamantes R. Health and Quality of Life Outcomes. 2019 Jan 11;17(1):8. doi: 10.1186/s12955-018-1063-z. PMID: 30634992

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain. Redón J, Usó R, Trillo JL, López C, Morales-Olivas F, Navarro J, Sanchís J, Gil V, Orozco-Beltrán D. International Journal of Cardiology. 2019 Oct 15;293:260-265. doi: 10.1016/j.ijcard.2019.05.071. PMID: 31229263

Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia. Bertomeu-González V, Soriano Maldonado C, Bleda-Cano J, Carrascosa-Gonzalvo S, Navarro-Perez J, López-Pineda A, Carratalá-Munuera C, Gil Guillén VF, Quesada JA, Brotons C, Orozco-Beltrán D. Atherosclerosis. 2019 Nov;290:80-86. doi: 10.1016/j.atherosclerosis.2019.09.007. PMID: 31593904

Proyectos
Referencia: PI16/02130
Título: Impacto de la auto-medición y el auto-ajuste de la medicación antihipertensiva en el control de la hipertensión arterial. Un ensayo clínico pragmático: estudio ADAMPA
Entidad Financiadora: Instituto de Salud Carlos III
Investigador principal: Jorge Navarro Pérez
Duración: 2017 – 2021
Presupuesto: 86.515 €

+ Información
Título: Análisis epidemiológico de la fibromialgia en la comunidad valenciana
Doctorando: Cabo Meseguer, Asensio Francisco
Director: Trillo Mata, Jose Luis; Cerdá Olmedo, Germán
Fecha: 25/02/2019
Universidad: Universidad Católica de Valencia San Vicente Mártir